The estimated Net Worth of Jacob A Orville is at least $2.13 million dollars as of 30 April 2024. Jacob Orville owns over 102 units of Exact Sciences stock worth over $925,893 and over the last 5 years Jacob sold EXAS stock worth over $1,203,594.
Jacob has made over 18 trades of the Exact Sciences stock since 2020, according to the Form 4 filled with the SEC. Most recently Jacob sold 102 units of EXAS stock worth $6,135 on 30 April 2024.
The largest trade Jacob's ever made was exercising 10,197 units of Exact Sciences stock on 23 February 2022 worth over $653,832. On average, Jacob trades about 2,882 units every 67 days since 2020. As of 30 April 2024 Jacob still owns at least 14,440 units of Exact Sciences stock.
You can see the complete history of Jacob Orville stock trades at the bottom of the page.
Jacob's mailing address filed with the SEC is C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON, WI, 53719.
Over the last 21 years, insiders at Exact Sciences have traded over $118,141,352 worth of Exact Sciences stock and bought 191,930 units worth $1,451,887 . The most active insiders traders include Kevin T Conroy, Edwin M Jr Kania et Maneesh Arora. On average, Exact Sciences executives and independent directors trade stock every 12 days with the average trade being worth of $1,667,056. The most recent stock trade was executed by Brian Baranick on 5 August 2024, trading 2,712 units of EXAS stock currently worth $173,893.
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
Exact Sciences executives and other stock owners filed with the SEC include: